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Pyruvate neutralizes peritoneal dialysate cytotoxicity: Maintained
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Pyruvate neutralizes peritoneal dialysate cytotoxicity: Maintained in-
tegrity and proliferation of cultured human mesothelial cells. Toxic
effects of commercially available peritoneal dialysate (PD) fluid include
damage to mesothelial cells (MC), causing a severely disturbed prolifer-
ation of cultured MC. We investigated the injury to the cell membrane (by
release of lactate dehydrogenase, LDH), the proliferation (by cell counts
and by 3H-thymidine incorporation), and optional the cytokine generation(by IL-i receptor-antagonist production, IL-i ra) of cultured human MC
during the 48 hours after a 30 minute exposure to PD containing either 35
mmollliter sodium lactate or sodium pyruvate. All solutions had a pH of
5.2 to 5.6 and were composed as standard PD. Glucose contents of 1.36
and 3.86 mmol/liter were tested. After exposure to the lactate-PD
containing 1.36% glucose, LDH activity was increased by more than 30%,
proliferation of MC was inhibited by more than 30%, and IL-i ra
production was reduced significantly when compared to pyruvate-PD and
the control solution. After preincubation with 3.86% glucose containing
PD, all negative effects became even more pronounced in the lactate
group whereas the MC maintained their integrity, rate of proliferation and
IL-I ra release after pre-exposure to pyruvate containing PD. These
results suggest that the acute toxic effects of commercially available PD on
the integrity, proliferation and IL-i ra production of MC can be avoided
by the use of sodium pyruvate instead of sodium lactate.
In chronic peritoneal dialysis there is a process of continuous
injury and regeneration of the mesothelial cells (MC) [1]. Perito-
neal biopsies obtained from patients on long-term CAPD fre-
quently show a reduction of mesothelial microvilli and of micropi-
nocytic vesicles, concomitant with a disrupture of the tight
junctions. With a long period of dialysis, the regeneration of
mesothelial cells fails and the peritoneum becomes denuded of its
mesothelial cells [2, 3]. MC line the peritoneal cavity in a single
cell layer, which functions as a biological barrier between the
peritoneal space and the circulation, and has important metabolic
and excretory functions which may play a role in peritoneal host
defence [4, 5]. Damage to the mesothelium has been proposed as
a factor causing loss of ultrafiltration and dialysis efficacy, which
might result in the relatively high rate of treatment failures
described in peritoneal dialysis patients [6, 7]. The mesothelial
injury could be caused by the toxicity of commercially available
peritoneal dialysate (PD) fluids. In vitro experiments indicate that
high glucose concentration [8], low pH and/or the lactate buffer of
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the standard PD lead to cytolysis, reduced proliferation and
impaired function of MC [8]. Similar results have been described
for cultured blastocytes: cells cultured with glucose and lactate
containing media showed reduced proliferation. An improved
proliferation of these cells, however, was observed when pyruvate
instead of lactate anions were added to the glucose-containing
culture media [9].
This paper presents the results of a study which was performed
to test the toxicity of a PD containing 35 mmol/liter sodium
pyruvate instead of sodium lactate. The integrity, rate of prolif-
eration and cytokine production of MC were tested after exposure
to the test solutions which had the pH (5.2 to 5.6) of standard
lactate-based PD solutions and contained 1.36% and 3.86%
glucose, respectively.
Methods
Isolation and identification of the cells
Human MC were isolated according to the method described by
Van Bronswijk et al [10]. A piece of human omentum, obtained
during abdominal surgery of patients with normal renal function,
was washed in Hank's solution and then incubated in a shaker in
0.05% trypsin-0.02% EDTA solution at 37°C. After 30 minutes
the tissue was removed and the trypsin solution, together with the
mesothelial cells, was centrifuged at 150 g for 10 minutes. The
same procedure was repeated with the remaining tissue two more
times. Supernatants were discarded, cells were washed once,
suspended in medium M199 (Sigma), which was supplemented
with 10% fetal calf serum (FCS, inactivated by heating to 57°C for
50 mm), and seeded into 75 cm2 culture flasks (Falcon). After
inactivation, no LDH was detectable in the FCS, as proven by
repeated testing (the method is below). Cells were cultured in a
humid air atmosphere with 5% CO2 at 37°c. The medium was
changed every two days. All experiments were repeated three
times with cells of one donor and were performed again with cells
of two more donors (3X each). Only cells from passages 1 and 2
were used.
Cells were identified by their typical cobblestone appearance
when grown to confluency. Furthermore, immunohistochemical
staining was performed with monoclonal antibodies to human
cytokeratin (to exclude the presence of fibroblasts) and to Factor
VIII (to exclude the presence of endothelial cells) as described in
detail elsewhere [8].
Test solutions
Four solutions were tested: The lactate- and the pyruvate-contain-
ing PD, both with 1.36% glucose and 3.86% glucose. The study
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solutions were produced as described elsewhere [111 and com-
posed as standard PD containing: calcium, 1.75 mmol/liter; mag-
nesium, 0.75 mmol/liter; sodium, 132 mmol/liter; chloride, 102
mmol/liter, and 35 mmol/liter of lactate and pyruvate anions,
respectively. The osmolality was approximately 340 mOsm/kg
(1.36% glucose) and 480 mOsm/kg (3.86% glucose), and the pH
of all solutions was adjusted to 5.2 to 5.6 by adding hydrochloric
acid as described elsewhere [11]. All solutions were sterilized by
filtration.
Mesothelial cell proliferation - Cell counts
MC were grown to confluent monolayers in culture flasks and
harvested with trypsin. Cells were then resuspended in M199 with
10% FCS and seeded into six-well tissue culture plates (Falcon) at
a density of 5 X io cells per well with 5 ml of M199. Cells were
allowed to attach to the bottom and to grow for five days, the
medium was changed every 24 hours. After the fifth day, cells
were washed with Hank's solution and exposed to the different
test solutions and to M199 as a control for 30 minutes. This
exposure time was chosen after preparing experiments which
demonstrated that exposures to lactate dialysate of more than 40
minutes leads to complete destruction of the cells. Short exposure
times (5 mm) produced no significant differences between the test
solutions.
After 30 minutes of exposure to the test solutions the cells were
washed twice with Hank's buffer and then incubated again for 48
hours with M199 containing 10% FCS; the medium was changed
once after 24 hours and the used medium was tested for lactate
dehydrogenase (LDH) content. After 48 hours supernatants were
retained for LDH and IL-i ra determination. Cells were harvested
with trypsin solution and counted in the hemocytometer. Results
are given as total cell counts per well (5 ml medium). For every
studied group nine wells were counted (3 for each donor).
Proliferation studies - 3H-thymidine incorporation
Proliferation of the MC was estimated indirectly on the basis of
incorporation of 3H-methyl-thymidine into growing cells. Cells
were seeded in 96-well culture plates at a density of i0 cells per
well. After five days the cells were exposed to the test solutions.
After 30 minutes of exposure to the test solutions the cells were
washed twice with Hank's buffer and then incubated again for 24
hours with M199 containing 10% FCS. Twenty-four hours after
the preincubation the medium of the 96-well culture plates was
replaced by fresh M199 supplemented with 3H-methyl-thymidine
(1 1.tCi/ml, Amersham). After a further 24 hours of incubation the
cells were harvested and precipitated with ice-cold 10% trichlo-
roacetic acid (TCA). The precipitated pellet was washed twice
with 10% TCA and finally with methanol, methanolether and
ether to remove water and dry it. Thereafter, the precipitated
pellet was dissolved in 1 N NaOH and samples were counted in a
beta-counter.
Lactate dehydrogenase release
To study the injury which the tested solutions induced in the
cell membrane, we measured the release of the cytosolic enzyme
LDH from the MC into the medium, 24 hours and 48 hours after
the preincubation experiments. The collected medium was filtered
to remove any dead or detached cells, and the LDH activity was
measured with the enzymatic kinetic method, based on the
oxidation of NADH to NAD during reduction of pyruvate cata-
lyzed by LDH (Sigma LDH test). Again, every studied group
consisted of nine wells, three from each donor.
IL-i receptor antagonist
IL-i ra was analyzed using a specific radioimmunoassay accord-
ing to the method previously described [121. IL-I ra was measured
after lyophilization and resuspension (final concentration 1:5) of
the medium collected 48 hours after the pre-exposure of the cells.
Results were adjusted for i04 cells. The mean sensitivity for the
IL-i ra assay was 166 pg!ml.
Statistical analysis
The results are expressed as mean SEM. The data were
analyzed using the non-parametric Mann-Whitney test for un-
paired data. A P value less than 0.05 was considered significant.
Results
Preincubation of MC to test solutions containing sodium lactate
resulted in significantly reduced proliferation when compared to
preincubation with the control solution M199, and this effect was
slightly enhanced by a higher glucose concentration (Fig. I).
When pyruvate was substituted for lactate, the cell counts after 48
hours were comparable to those found after preincubation with
M199. Even preexposition to the pyruvate solution with 3.86%
glucose showed no negative effects on MC counts.
These results were confirmed by the thymidine incorporation
studies (Fig. 2). In these experiments proliferation of MC was
measured indirectly by determination of the incorporation of
3H-thymidine into growing cells 24 hours after preincubation to
the test solutions. Whereas the thymidine incorporation was
markedly reduced after exposure of MC to lactate-PD (3.86%
glucose more than 1.36%), it was not different from controls after
pre-exposure to pyruvate-PD (neither 1.36 nor 3.86% glucose).
Exposure of MC to PD could decrease the number of cells
because of their accelerated cytolysis. To proof this mechanism,
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Fig. 1. Cell counts of mesothelial cells 48 hours after exposure to test
solutions containing either sodium lactate () or sodium pyruvate () and
1.36 or 3.86%, respectively. Controls (U) were exposed to M199. Every bar
is the mean value of 9 measurements. < 0.01.
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Fig. 2. Incorporation of the radioactive tymidine into proliferating mesothe-
hal cells 48 hours after exposure to test solutions containing either sodium
lactate () or sodium pyruvate () and 1.36 or 3.85% glucose, respectively.
Controls (U) were exposed to M199. Every bar is the mean value of 9
measurements. C 0.01.
Fig. 4. Concentration of IL-i ra in supernatants of mesothelial cells 48
hours after exposure to test solutions containing either sodium lactate () or
sodium pyruvate () and 1.36 or 3.86% glucose, respectively. Controls (U)
were exposed to M199. Every bar is the mean value of 9 measurements.
<0.01.
reduction of the IL-i ra generation by MC after pre-exposure to
lactate-PD containing 1.36% glucose, which reached significancy
when the solution contained 3.86% glucose (Fig. 4). Pre-exposure
to pyruvate-PD had no significant negative effect on IL-i ra
release when compared to the effect of exposure to control
solution (M199), neither with 1.36% glucose nor 3.86% glucose.
Discussion
Fig. 3. Concentrations of LDH in supematants of mesothelial cells, 24 and
48 hours after exposure to test solutions containing either sodium lactate or
sodium pyruvate and 1.36 or 3.86% glucose, respectively. Symbols are: ()
lactate 1.36; (rJ) lactate 3.86; (0) pyruvate 1.36; () pyruvate 3.86; (U)
control. Every bar is the mean of 9 measurements. *p C 0.01 compared to
controls.
we determined the release of cytosolic enzyme LDH in superna-
tants of MC 24 hours and 48 hours after preincubation with the
test solutions. The concentration of LDH was significantly in-
creased 24 hours after exposure to lactate-PD when compared to
controls and pyruvate-PD (Fig. 3). This effect was no longer
demonstrable 48 hours after exposure, neither when the pyru-
vate-PD contained 3.86% glucose nor when it contained 1.36%
glucose. When recalculated per amount of the cells in the well,
however, even after 48 hours there was a relatively higher (not
significant), LDH release by the cells which had been exposed to
the lactate dialysate.
To test the capacity for cytokine generation of MC after
exposure to the test solutions we investigated the IL-i ra gener-
ation. IL-i ra was determined in the supernatants of the MC-
cultures 48 hours after exposure to the test solutions. There was a
Mesothelial cells (MC) are continuously exposed to the poten-
tially toxic dialysate fluid and are known to show serious damage
in long-term CAPD therapy. The present study was performed to
test the toxicity of a newly formulated pyruvate-based dialysate on
human MC viability, proliferation and cytokine generation in
vitro. The experimental protocol imitated the conditions of pen-
toneal dialysis by exposing MC transiently to the test solutions.
The exposure time of 30 minutes, however, was relatively long
compared to the in vivo situation, where the low pH and the
lactate content are equilibrated to serum levels after 5 to 30
minutes of peritoneal dwell time, while glucose concentrations
decline much more slowly. On the other hand, cytotoxic effects of
the peritoneal effluent have been demonstrated even after pen-
toneal dwell times of more than 60 minutes {13J.
In our hands cultured MC exposed to standard lactate PD for
30 minutes exhibit cytolysis (measured by LDH-release) in the
first 24 hours after exposure and inhibition of cell proliferation
(determined by cell counting and 3H-methylthymidine incorpora-
tion) and cytokine generation (IL-i ra), both lasting for more than
24 hours after exposure to the test solutions. In contrast, MC
exposed to pyruvate based dialysate showed normal viability,
proliferation and cytokine production. The release of IL-i ra to
the medium was used as an indicator for the capacity of MC to
generate cytokines after preexposure to the different solutes. So
far the IL-i ra production by MC has not been described,
however, the release of IL-6 and IL-8 has recently been demon-
strated [14].
The cause and mechanism of the toxicity of standard PD has
been the objective of numerous experimental studies, since it
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could well explain some of the drawbacks of peritoneal dialysis in
clinical practice. In addition to the acute inhibitory effects on host
defence mechanisms (as phagocytic activity and cytokine release)
of peritoneal macrophages [4, 15, 16], the PD toxicity on MC
might be the cause of the dysfunction (such as ultrafiltration loss
and reduced dialysis efficacy) of the peritoneal membrane ob-
served in some patients on chronic peritoneal dialysis. The
cytotoxic properties of lactate-based CAPD dialysate have been
attributed to the high glucose content, to the low pH of the
dialysate and to the lactate anions.
As far as glucose cytotoxicity is concerned, glucose concentra-
tion of 60 to 90 mmol/liter reduces mesothelial cell proliferation
as demonstrated by Breborowitz, Rodela and Oreopoulos [81. In
endothelial cells proliferation is reduced by glucose concentra-
tions of 30 mmol/liter and, additionally, DNA damage has been
observed [17, 181. Furthermore, Seshagiri and Bavister [9] dem-
onstrated the inhibition of hamster blastocyte proliferation and
transformation in media containing 5 mmol/liter glucose in long-
term experiments. The biochemical mechanism of glucose-in-
duced inhibition of cell proliferation has been attributed by Koobs
et alto the so-called "Crabtree"-effect [19—211. These authors
have explained the glucose cytotoxicity in transformed cells by
inadequate glycolysis [9, 19]: high glucose may cause insufficient
energy generation because it presumably decreases the availability
of nicotinamide adenine dinucleotide and/or oxidative potential
and thereby reduces the oxidation of lactate to pyruvate.
The cytotoxicity of lactate seems to be related to the same
mechanism as that described for glucose. The toxic effects of
lactate have been underlined by Veech [22]. It is known that
peritoneal macrophages take up lactate preferentially in an acidic
environment, suggesting that these cells utilize lactate as an
energy source [231. We speculate that, caused by the "Crabtree-
effect" (induced by the high glucose concentrations), the lactate
oxidation is blocked and the energy generation by glycolysis
becomes impaired.
The hypothesis that high glucose inhibits lactate oxidation
under the condition of CAPD has to be verified by experiments
involving oxygen consumption and estimation of relevant enzyme
activities and metabolites in the presence and absence of glucose.
However, it is supported by the observation that high glucose
concentrations produce more immunosuppression and stronger
antiproliferative effects than low glucose concentrations [24]. The
role of lactate uptake is underlined by the fact that lactate is only
toxic at low pH [23]. Since there is experimental evidence that
acidic solutions containing both lactate and glucose inhibit meta-
bolic activity of cells more than solutions containing glucose or
lactate alone [9], we propose that there is a synergism between
lactate and glucose toxicity with respect to the inhibition of lactate
oxidation.
Parallel to the positive effects on host defense mechanisms,
demonstrated in peripheral and peritoneal leukocytes [25], pyru-
vate also neutralizes the negative effects of PD on mesothelial
cells. Our results are in accordance with those obtained by
Seshagiri and Bavister, who have demonstrated that the addition
of pyruvate to glucose containing media increases blastocyte
proliferation and development [9]. The new pyruvate-containing
dialysate might maintain mesothelial proliferation, integrity and
function by providing the cells with pyruvate as an alternative
energy source, which is not influenced by the blocking of lactate
oxidation ("Crabtree-effect").
PD containing sodium pyruvate (35 mmol/liter) should effi-
ciently correct metabolic acidosis of ESRD patients since the
serum half-life of pyruvate is no longer than 5 to 15 minutes
because of its rapid hepatic conversion to lactate. In an intrave-
nous pyruvate loading test, developed in patients suspected for
the rare Leigh's syndrome [26], it has been demonstrated that 500
mg/kg body weight of sodium pyruvate administered during ten
minutes is nontoxic and completely metabolized in 60 minutes.
Sodium pyruvate aqueous solutions can be prepared easily and
are stable, and should be applicable as peritoneal dialysate in
clinical practice without difficulties.
Reprint requests to Dr. Reinhard Bntnkhorst, Division of Nephrology,
Medical School Hannover, Konstant Gutschowstr. 8, 30625 Hannover,
Germany.
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